The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways

Dig Dis Sci. 2014 Jul;59(7):1406-14. doi: 10.1007/s10620-013-3015-0. Epub 2014 Jan 23.

Abstract

Background: Neutron irradiation (IR) has been proven to cause more serious damage than gamma IR. Preventing and curing neutron IR damage remains an urgent issue.

Aims: The objective of this study was to investigate the radioprotective effects of IL-11 against neutron IR-induced damage in small intestine of mice.

Methods: Mice were exposed to 3-Gy neutron IR whole body and then treated with 500 μg/kg interleukin-11 (IL-11) intraperitoneally every day. Mice were observed at various time-points over 1-5 days after IR. IEC-6 cells were exposed to 4 Gy neutron IR, and 100 ng/mL rhIL-11 was added to culture medium. Cell proliferation activity was estimated by MTT assay and rates of apoptosis were estimated by flow cytometry.

Results: IL-11 slightly alleviated the incidence of diarrhea in the mice and promoted intestinal epithelia regeneration. In the in vitro study, neutron IR activated extracellular signal-regulated kinase (ERK)1/2 phosphorylation in intestinal epithelial cells constitutively, which was initially suppressed and then activated later by IL-11. The MEK-specific inhibitor U0126 could antagonize the positive effect of IL-11 on cell growth. Phosphatidylinositol 3-kinase (PI3K)/Akt pathway activation was suppressed after neutron IR, but could be triggered by IL-11 to protect the cells. The PI3K inhibitor LY294002 suppressed the positive effect of IL-11 on cell growth, and antagonized the protective effect of IL-11 against cell death after neutron IR.

Conclusion: IL-11 increases cell proliferation after neutron IR in MEK and PI3K-dependent signaling pathways, but protects cells against death only in the PI3K-dependent signaling pathway.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Biomarkers / metabolism
  • Blotting, Western
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Cells, Cultured
  • Flow Cytometry
  • Injections, Intraperitoneal
  • Interleukin-11 / pharmacology*
  • Interleukin-11 / therapeutic use
  • Intestine, Small / drug effects*
  • Intestine, Small / metabolism
  • Intestine, Small / radiation effects*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / radiation effects
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neutrons*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Radiation Injuries, Experimental / drug therapy*
  • Radiation Injuries, Experimental / metabolism
  • Radiation-Protective Agents / pharmacology*
  • Radiation-Protective Agents / therapeutic use
  • Random Allocation
  • Rats
  • Signal Transduction / drug effects*
  • Treatment Outcome

Substances

  • Biomarkers
  • Interleukin-11
  • Radiation-Protective Agents
  • Proto-Oncogene Proteins c-akt